Shares of Sequenom (SQNM +6.9%) jump higher in early trading after the firm announces an expanded agreement with healthcare cost management firm Provider Multiplan to include the MaterniT21 fetal test at more than 900 providers in its network. The frothy bid for Human Genome is also adding to the bullish sentiment over Sequenom - viewed as a juicy takeover candidate itself.
Shares of Sequenom (SQNM +6.9%) jump higher in early trading after the firm announces an...
From other sites
at CNBC.com (Dec 3, 2014)
at CNBC.com (Jan 14, 2014)
at CNBC.com (Mar 15, 2013)
at CNBC.com (Apr 25, 2012)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs